US Patent

US12263162 — Compositions, devices, and methods for treating or preventing headaches

Formulation · Assigned to Satsuma Pharmaceuticals Inc · Expires 2039-12-11 · 14y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

Satsuma Pharmaceuticals Inc has patented compositions, devices, and methods for treating or preventing headaches.

USPTO Abstract

Disclosed herein are pharmaceutical compositions, devices, their combinations, and their uses thereof for example in treating or preventing headaches.

Drugs covered by this patent

dihydroergotamine-mesylate (DIHYDROERGOTAMINE MESYLATE)

Patent Metadata

Patent number: US12263162
Jurisdiction: US
Classification: Formulation
Expires: 2039-12-11
Drug substance claim: No
Drug product claim: Yes
Assignee: Satsuma Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.